These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Inhibition of IκB kinase reduces the multiple organ dysfunction caused by sepsis in the mouse. Coldewey SM; Rogazzo M; Collino M; Patel NS; Thiemermann C Dis Model Mech; 2013 Jul; 6(4):1031-42. PubMed ID: 23649820 [TBL] [Abstract][Full Text] [Related]
11. Renoprotective effect of erythropoietin in ischemia/reperfusion injury: possible roles of the Akt/endothelial nitric oxide synthase-dependent pathway. Oba S; Suzuki E; Nishimatsu H; Kumano S; Hosoda C; Homma Y; Hirata Y Int J Urol; 2012 Mar; 19(3):248-55. PubMed ID: 22126194 [TBL] [Abstract][Full Text] [Related]
12. Tissue protection by erythropoietin: new findings in a moving field. Nangaku M Kidney Int; 2013 Sep; 84(3):427-9. PubMed ID: 23989353 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological preconditioning with erythropoietin attenuates the organ injury and dysfunction induced in a rat model of hemorrhagic shock. Nandra KK; Collino M; Rogazzo M; Fantozzi R; Patel NS; Thiemermann C Dis Model Mech; 2013 May; 6(3):701-9. PubMed ID: 23264564 [TBL] [Abstract][Full Text] [Related]
15. Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury. Patel NS; Kerr-Peterson HL; Brines M; Collino M; Rogazzo M; Fantozzi R; Wood EG; Johnson FL; Yaqoob MM; Cerami A; Thiemermann C Mol Med; 2012 May; 18(1):719-27. PubMed ID: 22415011 [TBL] [Abstract][Full Text] [Related]
16. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism. Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808 [TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice. Luo CJ; Zhang FJ; Zhang L; Geng YQ; Li QG; Hong Q; Fu B; Zhu F; Cui SY; Feng Z; Sun XF; Chen XM Shock; 2014 Feb; 41(2):123-9. PubMed ID: 24169208 [TBL] [Abstract][Full Text] [Related]
18. Repurposing of High-Dose Erythropoietin as a Potential Drug Attenuates Sepsis in Preconditioning Renal Injury. Chancharoenthana W; Udompronpitak K; Manochantr Y; Kantagowit P; Kaewkanha P; Issara-Amphorn J; Leelahavanichkul A Cells; 2021 Nov; 10(11):. PubMed ID: 34831360 [TBL] [Abstract][Full Text] [Related]
19. Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock. Kapoor A; Shintani Y; Collino M; Osuchowski MF; Busch D; Patel NS; Sepodes B; Castiglia S; Fantozzi R; Bishop-Bailey D; Mota-Filipe H; Yaqoob MM; Suzuki K; Bahrami S; Desvergne B; Mitchell JA; Thiemermann C Am J Respir Crit Care Med; 2010 Dec; 182(12):1506-15. PubMed ID: 20693380 [TBL] [Abstract][Full Text] [Related]
20. β Common Receptor Mediates Erythropoietin-Conferred Protection on OxLDL-Induced Lipid Accumulation and Inflammation in Macrophages. Lee TS; Lu KY; Yu YB; Lee HT; Tsai FC Mediators Inflamm; 2015; 2015():439759. PubMed ID: 26101463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]